IL66637A - Expression and excretion of mature hepatitis b surface antigen in monkey kidney fibroblast cell culture transformed with a replicable dna expression vector - Google Patents
Expression and excretion of mature hepatitis b surface antigen in monkey kidney fibroblast cell culture transformed with a replicable dna expression vectorInfo
- Publication number
- IL66637A IL66637A IL66637A IL6663782A IL66637A IL 66637 A IL66637 A IL 66637A IL 66637 A IL66637 A IL 66637A IL 6663782 A IL6663782 A IL 6663782A IL 66637 A IL66637 A IL 66637A
- Authority
- IL
- Israel
- Prior art keywords
- excretion
- cell culture
- surface antigen
- monkey kidney
- fibroblast cell
- Prior art date
Links
- 241000282693 Cercopithecidae Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000004113 cell culture Methods 0.000 title 1
- 230000029142 excretion Effects 0.000 title 1
- 239000013604 expression vector Substances 0.000 title 1
- 210000002950 fibroblast Anatomy 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 210000003734 kidney Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29823581A | 1981-08-31 | 1981-08-31 | |
US32698081A | 1981-12-03 | 1981-12-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL66637A0 IL66637A0 (en) | 1982-12-31 |
IL66637A true IL66637A (en) | 1991-11-21 |
Family
ID=26970555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL66637A IL66637A (en) | 1981-08-31 | 1982-08-25 | Expression and excretion of mature hepatitis b surface antigen in monkey kidney fibroblast cell culture transformed with a replicable dna expression vector |
Country Status (17)
Country | Link |
---|---|
EP (2) | EP0291586A3 (ja) |
JP (3) | JPS5856685A (ja) |
AU (2) | AU555575B2 (ja) |
BR (1) | BR8205078A (ja) |
DE (1) | DE3280310D1 (ja) |
DK (1) | DK173592B1 (ja) |
ES (1) | ES515260A0 (ja) |
GB (1) | GB2105344B (ja) |
GR (1) | GR76906B (ja) |
HK (1) | HK29689A (ja) |
HU (1) | HU196238B (ja) |
IE (1) | IE53873B1 (ja) |
IL (1) | IL66637A (ja) |
KE (1) | KE3838A (ja) |
NO (1) | NO165598C (ja) |
NZ (1) | NZ201706A (ja) |
ZW (1) | ZW18282A1 (ja) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5196194A (en) * | 1979-05-24 | 1993-03-23 | The Regents Of The University Of California | Vaccines containing Hepatitis B S-protein |
US4769238A (en) | 1981-08-04 | 1988-09-06 | The Regents Of The University Of California | Synthesis of human virus antigens by yeast |
ZW18282A1 (en) * | 1981-08-31 | 1983-03-23 | Genentech Inc | Preparation of polypeptides in vertebrate cell culture |
JPS5936698A (ja) * | 1982-08-20 | 1984-02-28 | Science & Tech Agency | B型肝炎ウイルス遺伝子を組込んだ組換えdnaおよび形質転換動物細胞 |
CA1209501A (en) * | 1982-09-16 | 1986-08-12 | Nikos Panayotatos | Expression vector |
US4820642A (en) * | 1983-04-04 | 1989-04-11 | The Regents Of The University Of California | Amplified expression vector |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
NZ209308A (en) | 1983-08-30 | 1991-08-27 | Genentech Inc | Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein |
US7264817B1 (en) | 1983-08-30 | 2007-09-04 | Genentech, Inc. | Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it |
WO1985001516A1 (fr) * | 1983-10-03 | 1985-04-11 | Transgene S.A. | Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin |
FR2552776B1 (fr) * | 1983-10-03 | 1986-05-09 | Transgene Sa | Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin |
JPS6078999A (ja) * | 1983-10-05 | 1985-05-04 | Chemo Sero Therapeut Res Inst | HBs抗原の精製方法 |
US5639639A (en) * | 1983-11-02 | 1997-06-17 | Genzyme Corporation | Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof |
US5118627A (en) * | 1984-02-27 | 1992-06-02 | Amgen | Papova virus construction |
FR2560890B1 (fr) * | 1984-03-07 | 1987-10-16 | Grp Genie Genetique | Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention |
US4777240A (en) * | 1984-03-08 | 1988-10-11 | Scripps Clinic And Research Foundation | SV40 expression vector containing HBxAg as an expression marker |
US4855224A (en) * | 1984-03-09 | 1989-08-08 | Genentech, Inc. | Molecularly cloned diagnostic product and method of use |
US4663281A (en) * | 1984-03-22 | 1987-05-05 | Mass Institute Of Technology | Enhanced production of proteinaceous materials in eucaryotic cells |
FR2564106B1 (fr) * | 1984-05-09 | 1988-04-22 | Transgene Sa | Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix. |
US5683688A (en) | 1984-05-31 | 1997-11-04 | Genentech, Inc. | Unglycosylated recombinant human lymphotoxin polypeptides and compositions |
WO1986006405A1 (en) * | 1985-05-02 | 1986-11-06 | Takeda Chemical Industries, Ltd. | Novel transformant and its use |
EP0213628A3 (en) * | 1985-09-03 | 1988-09-21 | Yeda Research And Development Company, Ltd. | Expression of superoxide dismutase in eukaryotic cells |
SE8505027D0 (sv) * | 1985-10-24 | 1985-10-24 | Kabigen Ab | A lytic virulent phage, a hostcell containing same and a process for protein production |
EP0228036A3 (en) * | 1985-12-18 | 1988-09-07 | Microgenesys, Inc. | Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom |
AU582288B2 (en) * | 1986-03-07 | 1989-03-16 | Damon Biotech Inc. | Vector and method for achieving high level expression in eukaryotic cells |
US5004693A (en) * | 1986-07-18 | 1991-04-02 | E. I. Du Pont De Nemours And Company | Pseudorabies virus recombinants and their use in the production of proteins |
NZ219516A (en) * | 1987-02-10 | 1991-02-26 | Wellcome Found | Fusion proteins of hbcag (hepatitis b virus core antigen) |
US5024939A (en) * | 1987-07-09 | 1991-06-18 | Genentech, Inc. | Transient expression system for producing recombinant protein |
US5443964A (en) * | 1987-08-10 | 1995-08-22 | Duke University | Poxvirus insertion/expression vector |
US5578468A (en) * | 1987-08-10 | 1996-11-26 | Duke University | Site-specific RNA cleavage |
JPH01285196A (ja) * | 1988-05-11 | 1989-11-16 | Chisso Corp | 発光蛋白エクオリンの製造法 |
US5709995A (en) | 1994-03-17 | 1998-01-20 | The Scripps Research Institute | Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
JP4085231B2 (ja) | 2000-02-28 | 2008-05-14 | 株式会社ビークル | タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636191A (en) * | 1969-10-08 | 1972-01-18 | Cancer Res Inst | Vaccine against viral hepatitis and process |
US4164565A (en) * | 1975-03-14 | 1979-08-14 | New York Blood Center, Inc. | Vaccine for active immunization containing hepatitis B surface antigen and associated antigen |
FR2480779B2 (fr) * | 1979-08-30 | 1986-07-18 | Anvar | Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur |
FR2444713A1 (fr) | 1978-12-18 | 1980-07-18 | Pasteur Institut | Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant |
JP2530801B2 (ja) | 1978-12-22 | 1996-09-04 | バイオゲン インコーポレイテッド | 組換えdna分子 |
IE52036B1 (en) * | 1979-05-24 | 1987-05-27 | Univ California | Non-passageable viruses |
JPS5610119A (en) * | 1979-07-05 | 1981-02-02 | Alpha Therapeutic Corp | Manufacture of b type hepatitis infection preventive vaccine |
US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811895B (en) * | 1980-04-07 | 1982-04-28 | Univ California | Expression of hormone genomic clones |
DE3176404D1 (en) * | 1980-04-22 | 1987-10-08 | Pasteur Institut | Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine |
FR2480780B1 (fr) * | 1980-04-22 | 1985-12-06 | Pasteur Institut | Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn |
EP0062574A3 (en) * | 1981-03-31 | 1982-12-29 | The Regents Of The University Of California | Virus protein synthesis |
JPS5813598A (ja) * | 1981-06-22 | 1983-01-26 | イーライ・リリー・アンド・カンパニー | 組み替えdnaクロ−ニング・ベクタ−ならびにその真核細胞性および原核細胞性被形質転換体 |
ZW18282A1 (en) | 1981-08-31 | 1983-03-23 | Genentech Inc | Preparation of polypeptides in vertebrate cell culture |
NZ201705A (en) * | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4442205A (en) * | 1981-09-22 | 1984-04-10 | The United States Of America As Represented By The Department Of Health And Human Services | Simian virus recombinant that directs the synthesis of hepatitis B surface antigen |
AU561343B2 (en) * | 1981-10-19 | 1987-05-07 | Genentech Inc. | Human immune interferon by recombinant dna |
FR2521165A1 (fr) * | 1982-02-08 | 1983-08-12 | Pasteur Institut | Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus |
US4446235A (en) * | 1982-03-22 | 1984-05-01 | Genentech, Inc. | Method for cloning human growth hormone varient genes |
-
1982
- 1982-08-06 ZW ZW182/82A patent/ZW18282A1/xx unknown
- 1982-08-25 NZ NZ201706A patent/NZ201706A/en unknown
- 1982-08-25 IL IL66637A patent/IL66637A/xx not_active IP Right Cessation
- 1982-08-26 EP EP87202618A patent/EP0291586A3/en not_active Withdrawn
- 1982-08-26 EP EP82304512A patent/EP0073656B1/en not_active Revoked
- 1982-08-26 DE DE8282304512T patent/DE3280310D1/de not_active Revoked
- 1982-08-26 GB GB08224527A patent/GB2105344B/en not_active Expired
- 1982-08-26 ES ES515260A patent/ES515260A0/es active Granted
- 1982-08-27 IE IE2084/82A patent/IE53873B1/en not_active IP Right Cessation
- 1982-08-27 AU AU87798/82A patent/AU555575B2/en not_active Expired
- 1982-08-30 HU HU822777A patent/HU196238B/hu unknown
- 1982-08-30 NO NO822926A patent/NO165598C/no not_active IP Right Cessation
- 1982-08-30 DK DK198203869A patent/DK173592B1/da not_active IP Right Cessation
- 1982-08-30 GR GR69154A patent/GR76906B/el unknown
- 1982-08-30 JP JP57150627A patent/JPS5856685A/ja active Granted
- 1982-08-30 BR BR8205078A patent/BR8205078A/pt unknown
-
1986
- 1986-08-20 AU AU61671/86A patent/AU589673B2/en not_active Expired
-
1988
- 1988-10-25 KE KE3838A patent/KE3838A/xx unknown
-
1989
- 1989-04-06 HK HK296/89A patent/HK29689A/xx not_active IP Right Cessation
-
1993
- 1993-07-30 JP JP5189904A patent/JP2634371B2/ja not_active Expired - Lifetime
-
1995
- 1995-08-07 JP JP7201034A patent/JP2726641B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2726641B2 (ja) | 1998-03-11 |
GB2105344B (en) | 1985-10-09 |
GB2105344A (en) | 1983-03-23 |
EP0073656A2 (en) | 1983-03-09 |
NO165598B (no) | 1990-11-26 |
JPH0937777A (ja) | 1997-02-10 |
IL66637A0 (en) | 1982-12-31 |
BR8205078A (pt) | 1983-08-09 |
JPH06261748A (ja) | 1994-09-20 |
AU555575B2 (en) | 1986-10-02 |
DK173592B1 (da) | 2001-04-09 |
JPH0587518B2 (ja) | 1993-12-16 |
KE3838A (en) | 1988-12-02 |
EP0073656A3 (en) | 1984-10-24 |
DK386982A (da) | 1983-03-01 |
AU589673B2 (en) | 1989-10-19 |
IE53873B1 (en) | 1989-03-29 |
EP0291586A2 (en) | 1988-11-23 |
ES8401134A1 (es) | 1983-12-01 |
DE3280310D1 (de) | 1991-04-11 |
GR76906B (ja) | 1984-09-04 |
AU6167186A (en) | 1987-01-08 |
JPS5856685A (ja) | 1983-04-04 |
HU196238B (en) | 1988-10-28 |
IE822084L (en) | 1983-02-28 |
NZ201706A (en) | 1986-05-09 |
EP0291586A3 (en) | 1988-12-07 |
HK29689A (en) | 1989-04-14 |
ZW18282A1 (en) | 1983-03-23 |
NO165598C (no) | 1991-03-06 |
EP0073656B1 (en) | 1991-03-06 |
JP2634371B2 (ja) | 1997-07-23 |
NO822926L (no) | 1983-03-01 |
AU8779882A (en) | 1983-03-10 |
ES515260A0 (es) | 1983-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL66637A (en) | Expression and excretion of mature hepatitis b surface antigen in monkey kidney fibroblast cell culture transformed with a replicable dna expression vector | |
DK342785A (da) | Oxidoreduktaser til brug i blege- og/eller rengoeringsmidler og fremstilling heraf med mikroorganismer konstrueret ved rekombinant dna-teknologi | |
SG43220A1 (en) | Hepatitis surface antigen formed by recombinat dna techniques vaccines diagnostics cell lines and methods of forming same | |
DK155585D0 (da) | Immunometrisk analyse til samtidig paavisning af mindst to antigener samt analysesaet til brug ved analysen | |
HK39986A (en) | Improvements in and relating to hand tools | |
DE3574103D1 (en) | Fluid separation cells and spacers for use in these | |
HK39886A (en) | Improvements in and relating to hand tools | |
GB8712936D0 (en) | Induction of gene expression in yeast | |
GB2095497B (en) | Improvements in and relating to direction finding | |
DK21784D0 (da) | Fremgangsmade til samling af to praeisolerede roer samt en samlemuffe til brug ved udoevelse af fremgangsmaden | |
IL59813A0 (en) | Method and means to improve mass transfer in a gas-evolying electrolyte cell | |
JPS5738725A (en) | Delta antigen in stable form related to b type hepatitis and isolation thereof | |
GB2109675B (en) | Improvements in and relating to trestles | |
GB2112960B (en) | Improvements in and relating to positioning servomechanisms | |
GB2095983B (en) | Improvements in and relating to castors | |
PT75448B (en) | Improvements in and relating to wingsail craft and wingsails therefor | |
OA08238A (en) | Hepatitis B surface antigen formed by recombinant DNA techniques vaccines diagnostics cell lines and methods of forming same | |
GB2168602B (en) | Improvements in and relating to castors | |
GB2088507B (en) | Improvements in and relating to formwork | |
JPS57189618A (en) | Culture medium structure in mushroom culturing | |
ZA854594B (en) | Fluid separation cells and spacers for use in these | |
ZA783543B (en) | Improvements in and relating to plastic pipes | |
DE3169817D1 (en) | Improvements in and relating to the application of reactable reagents with substrates | |
ZA781119B (en) | Improvements in and relating to solar heaters | |
ZA78111B (en) | Improvements in and relating to pipe joints |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
EXP | Patent expired |